Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

GSK

Gsk (GSK)

Gsk Plc
일자:
정렬 기준:
 검색 관련기사 보기:LSE:GSK
일자시간출처헤드라인심볼기업
2024/11/2000:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
2024/11/1918:24Alliance NewsAlliance NewsGSK hails positive results for linerixibat in treating relentless itchLSE:GSKGsk Plc
2024/11/1918:24Alliance NewsAlliance NewsGSK hails positive results for linerixibat in treating relentless itchLSE:GSKGsk Plc
2024/11/1916:00RNS Regulatory NewsGSK PLC GLISTEN Trial of Linerixibat Meets EndpointLSE:GSKGsk Plc
2024/11/1417:54Alliance NewsAlliance NewsGSK hails survival results in blood cancer patients with BlenrepLSE:GSKGsk Plc
2024/11/1417:54Alliance NewsAlliance NewsGSK hails survival results in blood cancer patients with BlenrepLSE:GSKGsk Plc
2024/11/1416:00RNS Regulatory NewsGSK PLC GSK announces overall survival results for BlenrepLSE:GSKGsk Plc
2024/11/1400:00RNS Regulatory NewsGSK PLC Block listing Interim ReviewLSE:GSKGsk Plc
2024/11/1300:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
2024/11/1200:01RNS Regulatory NewsGSK PLC GSK publishes provisional 2025 dividend datesLSE:GSKGsk Plc
2024/11/0501:16Alliance NewsAlliance NewsDIRECTOR DEALINGS: Drachs ups stake in Metals Exploration as CFO sellsLSE:GSKGsk Plc
2024/11/0501:16Alliance NewsAlliance NewsDIRECTOR DEALINGS: Drachs ups stake in Metals Exploration as CFO sellsLSE:GSKGsk Plc
2024/11/0200:00RNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
2024/10/3023:29RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
2024/10/3018:28Alliance NewsAlliance NewsTOP NEWS: GSK backs guidance despite third-quarter hit from ZantacLSE:GSKGsk Plc
2024/10/3018:28Alliance NewsAlliance NewsTOP NEWS: GSK backs guidance despite third-quarter hit from ZantacLSE:GSKGsk Plc
2024/10/3016:00RNS Regulatory NewsGSK PLC 3rd Quarter ResultsLSE:GSKGsk Plc
2024/10/2921:48Alliance NewsAlliance NewsGSK inks deal to buy lupus therapy from Chimagen for USD300 millionLSE:GSKGsk Plc
2024/10/2921:48Alliance NewsAlliance NewsGSK inks deal to buy lupus therapy from Chimagen for USD300 millionLSE:GSKGsk Plc
2024/10/2417:22Alliance NewsAlliance NewsIN BRIEF: GSK says Arexvy vaccine tests show wider potential for RSVLSE:GSKGsk Plc
2024/10/2417:22Alliance NewsAlliance NewsIN BRIEF: GSK says Arexvy vaccine tests show wider potential for RSVLSE:GSKGsk Plc
2024/10/2415:00RNS Regulatory NewsGSK PLC New positive Arexvy data in younger adults at riskLSE:GSKGsk Plc
2024/10/1723:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
2024/10/1700:09RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
2024/10/1616:33Alliance NewsAlliance NewsGSK's application for urinary tract infections drug is acceptedLSE:GSKGsk Plc
2024/10/1616:33Alliance NewsAlliance NewsGSK's application for urinary tract infections drug is acceptedLSE:GSKGsk Plc
2024/10/1615:00RNS Regulatory NewsGSK PLC FDA accepts new drug application for gepotidacinLSE:GSKGsk Plc
2024/10/1423:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
2024/10/1416:54Alliance NewsAlliance NewsTOP NEWS: GSK gets positive result from sinus disease treatment trialsLSE:GSKGsk Plc
2024/10/1416:54Alliance NewsAlliance NewsTOP NEWS: GSK gets positive result from sinus disease treatment trialsLSE:GSKGsk Plc
 검색 관련기사 보기:LSE:GSK